DAVID NEWSOME: Open Payments
NPI 1932634813 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 29 payments from 13 companies in 2025. Trend: 2023 $713 · 2024 $778 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $160 |
| ABBVIE INC. | 3 | $87 |
| PFIZER INC. | 3 | $58 |
| Astellas Pharma US Inc | 3 | $55 |
| Lilly USA, LLC | 2 | $39 |
| Novo Nordisk Inc | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Exact Sciences Corporation | 1 | $26 |
| Dexcom, Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
Products named: BREZTRI, QULIPTA, Veozah, Ozempic, AIRSUPRA, ELIQUIS, XIFAXAN, VRAYLAR.
Industry payments across LA — which companies pay providers there.
